Small, mid-tier & large cap Pharmaceutical & Biotechnology Companies

Development stage preclinical, PIND/IND & clinical Phase I-III assets

CROs – expert services/consulting

Other consulting firms – fill critical talent GAPs

Venture capital investors, institutions & investment bankers

Universities, companies & institutions interested in out-licensing/cross-licensing